Journal of Natural Products
ARTICLE
ꢀ
1
1
13
1
9
(
62 cm
;
H NMR data (CDCl
3
), see Table 1; C NMR data
(S)-MTPA Ester of 4 (4b): H NMR (CDCl
3
) δ 6.08 (H-5, H-30),
þ
CDCl ), see Table 1; HRESIMS m/z 463.3524 [M þ Na] (calcd
6.02 (H-3, H-32), 5.61 (H-4, H-31), 5.35 (H-13, H-14, H-19, H-20),
2.60 (H-1, H-34), 2.09 (H-6, H-29), 2.02 (H-12, H-15, H-18, H-21),
1.26ꢀ1.39 (H-7ꢀH-11, H-16ꢀH-17, H-22ꢀH-28); ESIMS m/z 949
3
for C30
H
48
O
2
Na, 463.3552).
26
D
(
ꢀ)-Duryne B (2): white solids; [R]
ꢀ17 (c 0.34, CHCl
3
); UV
þ
(
2
MeOH) λ (log ε) 206 (3.57); IR (film) ν 3440ꢀ3400 (br), 2916,
[M þ Na] .
max
max
ꢀ
1
1
1
849, 2121, 1647, 1468, 1215 cm ; H NMR data (CDCl ), see
(R)-MTPA Ester of 5 (5a): H NMR (CDCl
) δ 6.04 (H-3, H-34),
3
3
13
Table 1; C NMR data (CDCl
3
), see Table 1; HRESIMS m/z 491.3857
6.02 (H-5, H-32), 5.50 (H-4, H-33), 5.35 (H-15, H-16, H-21, H-22),
2.64 (H-1, H-36), 2.05 (H-6, H-31), 2.02 (H-14, H-17, H-20, H-23),
1.26ꢀ1.37 (H-7ꢀH-13, H-18ꢀH-19, H-24ꢀH-30); ESIMS m/z 977
þ
[
M þ Na] (calcd for C32
52 2
H O Na, 491.3865).
25
(
ꢀ)-Duryne C (3): white solids; [R]
D
ꢀ61 (c 0.05, CHCl
3
); UV
þ
(
3
MeOH) λ (log ε) 207 (3.60); IR (film) ν 3400ꢀ3360 (br), 3307,
[M þ Na] .
max
max
ꢀ
1
1
1
005, 2925, 2853, 2118, 1655, 1459, 1012, 968 cm ; H NMR data
(S)-MTPA Ester of 5 (5b): H NMR (CDCl
3
) δ 6.08 (H-5, H-32),
13
(CDCl
3
), see Table 2; C NMR data (CDCl
3
), see Table 2; HRESIMS
Na, 489.3708).
ꢀ38 (c 0.22, CHCl ); UV
6.02 (H-3, H-34), 5.61 (H-4, H-33), 5.35 (H-15, H-16, H-21, H-22),
2.60 (H-1, H-36), 2.09 (H-6, H-31), 2.02 (H-14, H-17, H-20, H-23),
1.27ꢀ1.41 (H-7ꢀH-13, H-18ꢀH-19, H-24ꢀH-30) ESIMS m/z 977
þ
m/z 489.3706 [M þ Na] (calcd for C 23 2
H
50 2
O
6
(
ꢀ)-Duryne D (4): white solids; [R]
D
3
þ
(
2
(
MeOH) λmax (log ε) 206 (3.59); IR (film) νmax 3400ꢀ3340 (br), 3290,
[M þ Na] .
ꢀ
1
1
1
997, 2920, 2849, 2120, 1654, 1459, 1215, 964 cm ; H NMR data
(R)-MTPA Ester of 6 (6a): H NMR(CDCl
) δ6.04 (H-3), 6.02 (H-5),
3
13
CDCl ), see Table 2; C NMR data (CDCl ), see Table 2; HRESIMS
5.95 (H-28), 5.83 (H-29), 5.64 (H-30), 5.36 (H-15, H-16), 5.50 (H-4),
3.25 (H-32), 2.64 (H-1), 2.05 (H-6), 2.02 (H-14, H-17), 1.81 (H-27R),
1.68 (H-27β), 1.26ꢀ1.36 (H-7ꢀH-13, H-18ꢀH-26); ESIMS m/z 923
3
3
þ
m/z 517.3986 [M þ Na] (calcd for C H O Na, 517.4021).
3
4 54 2
2
6
(
ꢀ)-Duryne E (5): white solids; [R]
D
ꢀ120 (c 0.02, MeOH); UV
1
þ
(
MeOH) λmax (log ε) 210 (3.73); H NMR data (CDCl ), see Table 2;
3
[M þ Na] .
1
3
1
C NMR data (CDCl ), see Table 2; HRESIMS m/z 545.4351
(S)-MTPA Ester of 6 (6b): H NMR (CDCl
3
) δ 6.08 (H-5), 6.02 (H-
3
þ
[
M þ Na] (calcd for C36
H
58
O
2
Na, 545.4334).
3), 6.00 (H-29), 5.96 (H-28), 5.67 (H-30), 5.61 (H-4), 5.36 (H-15,
H-16), 3.26 (H-32), 2.60 (H-1), 2.09 (H-6), 2.02 (H-14, H-17), 1.74
(H-27R), 1.23ꢀ1.61 (H-7ꢀH-13, H-18ꢀH-26, H-27β); ESIMS m/z
26
D
(
ꢀ)-Duryne F (6): white solids; [R]
ꢀ32 (c 0.04, CHCl
3
); UV
(
2
MeOH) λmax (log ε) 225 (3.76); IR (film) νmax 3400ꢀ3360 (br), 3308,
ꢀ
1 1
þ
922, 2851, 2120, 1655, 1459, 1014, 968 cm ; H NMR data (CDCl ),
923 [M þ Na] .
3
13
see Table 1; C NMR data (CDCl
3
), see Table 1; HRESIMS m/z
Na, 491.3865).
Ozonolysis. Separately, solutions of acetylenes 2ꢀ6 (0.5 mg each)
4
91.3846 [M þ Na]þ (calcd for C32
H
52
O
2
in CH
2
Cl
2
(1 mL) were treated with O
3
at ꢀ78 °C for 15 min. After
excess O was removed by a stream of N , the reaction mixtures were
treated with 90% HCOOH/35% H O (2:1, 1 mL) at room tempera-
ture for 15 min. The products were concentrated and subjected to
FABMS without further separation.
Preparation of MTPA Esters. To solutions of samples 1ꢀ6 (0.1
3
2
mg each) in dry pyridine (10 μL) was added (S)-MTPACl (2 μL). The
2 2
solutions were left at room temperature for 15 h, and the reaction mixtures
were diluted with H
were purified by reversed-phase HPLC to afford the (R)-MTPA esters.
S)-MTPA esters were prepared in a similar way using (R)-MTPACl.
R)-MTPA Ester of 1 (1a): H NMR (CDCl
.02 (H-5, H-26), 5.50 (H-4, H-27), 5.35 (H-15, H-16), 2.64 (H-1,
2 3
O and extracted with CHCl . The organic layers
Cytotoxicity Assay. The cytotoxicities of 1ꢀ6 against HeLa cells
2
4
were evaluated by an MTT assay. HeLa human cervical cancer cells
were cultured in Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum, 2 μg/mL gentamycin, and 2 μg/mL antibio-
(
1
(
3
) δ 6.04 (H-3, H-28),
6
ticꢀantimicotic (Gibco) at 37 °C under an atmosphere of 5% CO
2
.
H-30), 2.05 (H-6, H-25), 2.02 (H-14, H-17), 1.26ꢀ1.36 (H-7ꢀH-13,
þ
To each well of a 96-well microplate containing 200 μL of tumor cell
H-18ꢀH-24): ESIMS m/z 895 [M þ Na] .
4
1
suspension (1 ꢁ 10 cells/mL) was added a sample after 24 h
(
S)-MTPA Ester of 1 (1b): H NMR (CDCl
3
) δ 6.08 (H-5, H-26),
preincubation, and the plate was incubated for 72 h. After addition of
6
.02 (H-3, H-28), 5.61 (H-4, H-27), 5.35 (H-15, H-16), 2.60 (H-1,
3
-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
saline solution (1 mg/mL, 50 μL) to each well, the plate was incubated
for 3 h. After the incubation, the supernatant was discarded and DMSO
150 μL) was added. The absorbance was measured to determine
IC50 values. In this assay, adriamycin was used as a positive control
IC50 1.64 μM).
H-30), 2.09 (H-6, H-25), 2.02 (H-14, H-17), 1.27ꢀ1.39 (H-7ꢀH-13,
þ
H-18ꢀH-24): ESIMS m/z 895 [M þ Na] .
1
(
R)-MTPA Ester of 2 (2a): H NMR (CDCl
3
) δ 6.04 (H-3, H-30),
(
6
.02 (H-5, H-28), 5.50 (H-4, H-29), 5.35 (H-15, H-16), 2.64 (H-1,
H-32), 2.05 (H-6, H-27), 2.02 (H-14, H-17), 1.26ꢀ1.37 (H-7ꢀH-13,
þ
(
H-18ꢀH-26); ESIMS m/z 923 [M þ Na] .
1
(
S)-MTPA Ester of 2 (2b): H NMR (CDCl
3
) δ 6.08 (H-5, H-28),
6
.02 (H-3, H-30), 5.61 (H-4, H-29), 5.35 (H-15, H-16), 2.60 (H-1,
’ ASSOCIATED CONTENT
Supporting Information. NMR data and tandem FABMS
H-32), 2.09 (H-6, H-27), 2.02 (H-14, H-17), 1.27ꢀ1.40 (H-7ꢀH-13,
þ
S
H-18ꢀH-26); ESIMS m/z 923 [M þ Na] .
b
1
(
R)-MTPA Ester of 3 (3a): H NMR (CDCl
3
) δ 6.04 (H-3, H-30),
data for 1ꢀ6and photograph of the sponge. This material is available
6
2
1
.02 (H-5, H-28), 5.50 (H-4, H-29), 5.35 (H-11, H-12, H-17, H-18),
.64 (H-1, H-32), 2.05 (H-6, H-27), 2.02 (H-10, H-13, H-16, H-19),
.27ꢀ1.38 (H-7ꢀH-9, H-14ꢀH-15, H-20ꢀH-26); ESIMS m/z 921
free of charge via the Internet at http://pubs.acs.org.
’ AUTHOR INFORMATION
þ
[M þ Na] .
1
Corresponding Author
*
(
S)-MTPA Ester of 3 (3b): H NMR (CDCl ) δ 6.08 (H-5, H-28),
3
Tel: 81-3-5841-5297. Fax: 81-3-5841-8166. E-mail: assmats@
6
2
1
.02 (H-3, H-30), 5.61 (H-4, H-29), 5.35 (H-11, H-12, H-17, H-18),
.60 (H-1, H-32), 2.09 (H-6, H-27), 2.02 (H-10, H-13, H-16, H-19),
.27ꢀ1.40 (H-7ꢀH-9, H-14ꢀH-15, H-20ꢀH-26); ESIMS m/z 921 [M
mail.ecc.u-tokyo.ac.jp.
þ
þ Na] .
1
’ ACKNOWLEDGMENT
(
3
R)-MTPA Ester of 4 (4a): H NMR (CDCl ) δ 6.04 (H-3, H-32),
6
2
1
.02 (H-5, H-30), 5.50 (H-4, H-31), 5.35 (H-13, H-14, H-19, H-20),
.64 (H-1, H-34), 2.05 (H-6, H-29), 2.02 (H-12, H-15, H-18, H-21),
The sponge was collected during the NT-09-17 cruise of
Natsushima, JAMSTEC Japan Agency for Marine-Earth Science
and Technology. We thank Dr. Y. Ito, JEOL, for valuable advice
about the measurement of tandem FABMS.
.26ꢀ1.36 (H-7ꢀH-11, H-16ꢀH-17, H-22ꢀH-28); ESIMS m/z 949
þ
[M þ Na] .
1
266
dx.doi.org/10.1021/np200271n |J. Nat. Prod. 2011, 74, 1262–1267